Provided by Tiger Fintech (Singapore) Pte. Ltd.

60 degrees pharmaceuticals, Inc.

2.01
-0.2450-10.86%
Post-market: 2.010.00000.00%19:49 EDT
Volume:34.67K
Turnover:71.10K
Market Cap:2.96M
PE:-0.28
High:2.25
Open:2.18
Low:1.95
Close:2.26
Loading ...

H.C. Wainwright Remains a Hold on 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
08 Jan

BRIEF-60 Degrees Pharmaceuticals Enrolls First Patient In Tafenoquine Expanded Access Clinical Study

Reuters
·
08 Jan

60 Degrees Pharmaceuticals enrolls first patient in tafenoquine study

TIPRANKS
·
08 Jan

60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. Microti) Babesiosis

THOMSON REUTERS
·
08 Jan

60 Degrees Pharmaceuticals Enrolls First Patient in Tafenoquine Expanded Access Clinical Study for Persistent (B. microti) Babesiosis

GlobeNewswire
·
08 Jan

Analysts Offer Insights on Healthcare Companies: 60 Degrees Pharmaceuticals, Inc. (SXTP), Ionis Pharmaceuticals (IONS) and Zura Bio (ZURA)

TIPRANKS
·
25 Dec 2024

H.C. Wainwright Remains a Hold on 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
24 Dec 2024

60 Degrees signs patent license deal with Tufts Medical, says H.C. Wainwright

TIPRANKS
·
24 Dec 2024

60 Degrees Pharmaceuticals, Tufts Medical Center Sign Patent License Deal Over Potential Babesiosis Treatment

MT Newswires Live
·
23 Dec 2024

60 Degrees, Tufts Medical Center announces patent license agreement

TIPRANKS
·
23 Dec 2024

Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention

THOMSON REUTERS
·
23 Dec 2024

Sixty Degrees Pharmaceuticals and Tufts Medical Center Announce Patent License Agreement to Advance Development of Tafenoquine for Babesiosis Treatment and Prevention

GlobeNewswire
·
23 Dec 2024

H.C. Wainwright Sticks to Its Hold Rating for 60 Degrees Pharmaceuticals, Inc. (SXTP)

TIPRANKS
·
11 Dec 2024

60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

THOMSON REUTERS
·
11 Dec 2024

60 Degrees Pharmaceuticals Expands Tafenoquine Clinical Trial for Babesiosis to Brigham and Women’s Hospital

GlobeNewswire
·
11 Dec 2024